COLOGNE, GERMANY / ACCESSWIRE / June 28, 2018 / CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors today announced the ...

COLOGNE, GERMANY / ACCESSWIRE / February 9, 2017 / CEVEC Pharmaceuticals GmbH (CEVEC), the expert in the production of tailor-made recombinant glycoproteins and gene therapy vectors, today announced ...

Cologne, Germany, December 21, 2010 / b3c newswire / - CEVEC Pharmaceuticals, the developer of the CAP® protein expression system derived from human amniocytes, today announced that Rainer Christine ...

ELEVECTA(R) takes viral vector manufacturing to the next level to serve the rapidly growing market of gene therapy applications Growing serum-free in suspension, ELEVECTA(R) producer cell lines enable ...

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities. Cytiva has acquired CEVEC Pharmaceuticals, a Germany-based provider of ...

CEVEC Pharmaceuticals has announced its new management team: Wolfgang Kintzel remains Chief Executive Officer, Dr. Nicole Faust is appointed Chief Scientific Officer, Dr. Hartmut Tintrup is appointed ...

The new cell-line producing platform enables fully scalable production of high-performance adeno-associated virus vectors. On April 28, 2020, Cevec Pharmaceuticals announced the launch of the ELEVECTA ...

Jed Seifert says his greatest moment of last year was the day he walked into Stakes Manufacturing in Eastlake to see an older couple he didn’t recognize. After introductions were made, Seifert learned ...